The 6 analysts offering 12-month price forecasts for Amneal Pharmaceuticals Inc have a median target of 6.75, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +39.90% increase from the last price of 4.83.
The current consensus among 8 polled investment analysts is to Buy stock in Amneal Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.18
Reporting Date Aug 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.